VCA
RMTI icon

Verdence Capital Advisors’s Rockwell Medical RMTI Stock Holding History

Verdence Capital Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,370
Closed -$24.8K – 552
2023
Q1 		$24.8K Sell
1,370
-4,999
-78% -$86.1K ﹤0.01% 533
2022
Q4 		$64.6K Hold
6,369
– – 0.01% 489
2022
Q3 		$84K Sell
6,369
-800
-11% -$12.1K 0.01% 507
2022
Q2 		$92K Buy
7,169
+2,300
+47% +$60.8K 0.01% 502
2022
Q1 		$252K Buy
4,869
+837
+21% +$35.5K 0.03% 459
2021
Q4 		$182K Buy
4,032
+809
+25% +$43.3K 0.02% 482
2021
Q3 		$211K Buy
3,223
+275
+9% +$20.9K 0.03% 465
2021
Q2 		$295K Buy
2,948
+1,687
+134% +$174K 0.04% 368
2021
Q1 		$161K Sell
1,261
-869
-41% -$128K 0.03% 425
2020
Q4 		$237K Buy
2,130
+484
+29% +$54.2K 0.04% 349
2020
Q3 		$194K Buy
+1,646
New +$285K 0.04% 339

Other funds holding RMTI

RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Verdence Capital Advisors's RMTI Position: Q2 2023 in Review

Verdence Capital Advisors sold out of Rockwell Medical (RMTI) in Q2 2023, closing a stake of 1,370 shares — an estimated $24.8K sold.

Verdence Capital Advisors first reported a position in RMTI in Q3 2020 and held it in 11 quarters. The position peaked at $295K in Q2 2021. 40 funds tracked by Wall St. Rank hold RMTI as of Q2 2023.

  • Verdence Capital Advisors reported no remaining Rockwell Medical position as of Q2 2023 after selling out during the quarter.
  • Verdence Capital Advisors sold 1,370 Rockwell Medical shares in Q2 2023, an estimated $24.8K.
  • Verdence Capital Advisors first reported a position in Rockwell Medical in Q3 2020 and held it in 11 quarters.
  • Verdence Capital Advisors's Rockwell Medical position peaked at $295K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2023.

Based on Verdence Capital Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.